Patent · US Active

Pyrrolopyrazoles as N-type calcium channel blockers

US8846949B2 · kind B2 · utility

9Cited by

0References

17Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Michael Winters · Morgantown, US
Zhihua Sui · Flemington, US

Key dates

Filing date	Aug 16, 2013
Grant date	Sep 30, 2014
Priority date	—
Expiry date	Aug 16, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula I as follows:wherein R1, R2, R3, Q, and G are defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.